Скачать или смотреть S1 Episode 4: Triple-Class Refractory Multiple Myeloma: What Is the Approach? What Are the Challe...

Joseph Mikhael, MD, and Saad Usmani, MD, discuss options in managing triple-class refractory multiple myeloma including selinexor, belantamab mafodotin, and CAR T-cell therapy.


Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/.... The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.


Resources


Multiple Myeloma https://emedicine.medscape.com/articl...


Selinexor Prescribing Information https://www.karyopharm.com/wp-content...


Belantamab Mafodotin Prescribing Information https://gskpro.com/content/dam/global...


Cytokine Release Syndrome https://emedicine.medscape.com/articl...


Trending Clinical Topic: CAR T-cell Therapy https://reference.medscape.com/viewar...


Consensus Recommendations for the Clinical Management of Patients With Multiple Myeloma Treated With Selinexor https://www.karyopharm.com/wp-content...


Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma Patients https://www.ncbi.nlm.nih.gov/pmc/arti...


Once Weekly Selinexor, Carfilzomib, and Dexamethasone (XKd) in Carfilzomib Nonrefractory Multiple Myeloma (MM) Patients. https://ascopubs.org/doi/abs/10.1200/...


Ide-cel Prescribing Information https://packageinserts.bms.com/pi/pi_...


Belantamab Mafodotin for Relapsed or Refractory Multiple Myeloma (DREAMM-2): A Two-Arm, Randomised, Open-label, Phase 2 Study https://linkinghub.elsevier.com/retri...


DREAMM Trials https://dreammtrials.com/


Blenrep (Belantamab Mafodotin) REMS https://www.accessdata.fda.gov/script...


Band Keratopathy https://emedicine.medscape.com/articl...


Cilta-cel Prescribing Information https://www.fda.gov/media/156560/down...


BCMA-Directed CAR T-cell Therapy in Adult Patients With Relapsed and/or Refractory Multiple Myeloma https://clinicaltrials.gov/ct2/show/N...